Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

κ-Actin Activators

κ-Actin activators are a class of chemical compounds that target the cellular cytoskeletal structure, specifically the actin filaments. Actin is a highly conserved protein that forms microfilaments within eukaryotic cells and plays a crucial role in maintaining cell shape, enabling cell movement, and facilitating various forms of intracellular transport. The dynamic nature of actin polymerization and depolymerization is essential for these processes, and it is regulated by a host of actin-binding proteins. κ-Actin activators interact with these systems to modulate the behavior of actin. By doing so, they affect the organization and stability of actin filaments, which in turn can influence the physical properties of the cytoskeleton. Unlike other actin-targeting agents that may stabilize or sever filaments, κ-Actin activators specifically enhance the activity of actin by increasing its ability to form filaments without directly binding to actin monomers.

The mechanism of action of κ-Actin activators involves the modulation of proteins that regulate actin dynamics. These activators can work by influencing the function of actin nucleation factors, which are pivotal in the formation of new actin filaments. They may also affect the activity of severing proteins, which control the disassembly of filaments, or they might act on proteins that cap the growing ends of filaments to prevent further elongation. By altering the activity of these regulatory proteins, κ-Actin activators can potentially lead to changes in the rate of actin filament turnover and the organization of the actin cytoskeleton. The precise alterations induced by these activators depend on the specific regulatory pathways they target and the context within which they are acting, such as the cell type and the presence of other regulatory signals. As such, the influence of κ-Actin activators is highly specific and can result in a diverse range of effects on cellular actin structures.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates protein kinase C, which is involved in signaling pathways that can lead to changes in gene expression.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

This cAMP analog can mimic the action of cAMP and potentially induce changes in gene expression through the cAMP response element (CRE).

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Lithium may inhibit glycogen synthase kinase 3, thereby potentially influencing Wnt signaling and gene expression.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid can modulate gene expression through its role as an active metabolite of vitamin A, affecting cell differentiation.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

As a glucocorticoid, dexamethasone can influence gene expression through the glucocorticoid receptor pathway.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

TSA is a histone deacetylase inhibitor, which can affect chromatin structure and gene expression.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

As a histone deacetylase inhibitor, sodium butyrate can affect gene expression by altering chromatin accessibility.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This compound can inhibit DNA methyltransferase, leading to alterations in DNA methylation and gene expression.

Mycophenolic acid

24280-93-1sc-200110
sc-200110A
100 mg
500 mg
$69.00
$266.00
8
(1)

Mycophenolic acid can inhibit inosine monophosphate dehydrogenase, leading to changes in guanine nucleotide synthesis and gene expression.